Brief: Mauna Kea Technologies: Success Of Clinical Trial On Prediction Of Remission In Patients With Inflammatory Bowel Disease
Oct 31 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES SUCCESS OF CLINICAL TRIAL
ON
PREDICTION OF REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL
DISEASE (IBD) AND ITS PUBLICATION IN GASTROENTEROLOGY
Source text for Eikon: ID:nBwzlMQTa
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus